These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 43234)

  • 1. Metabolism of a new analgesic agent, dl-erythro-1-phenyl-2-(o-chlorophenyl)-2-[4-(p-methoxybenzyl)-1-piperazinyl]ethanol dihydrochloride, in rats.
    Hashimoto M; Sekine Y; Muto J; Yamaguchi T; Maeda T; Utsui Y; Yoshida K; Arakawa S; Shimokawa N; Shimakawa K
    Drug Metab Dispos; 1979; 7(6):435-41. PubMed ID: 43234
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological studies of a new analgesic, dl-erythro-1-phenyl-2-(o-chlorophenyl)-2-[4-(p-methoxybenzyl)-1-piperazinyl] ethanol dihydrochloride, in experimental animals.
    Nakamura H; Ishii K; Yokoyama Y; Motoyoshi S; Imazu C; Shimizu M
    Experientia; 1979 Mar; 35(3):369-70. PubMed ID: 446620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid in vivo metabolism of a methylether derivative of (+/-)-BW373U86: the metabolic fate of [3H]SNC121 in rats.
    Schetz JA; Calderon SN; Bertha CM; Rice K; Porreca F
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1069-76. PubMed ID: 8968326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of 4-(3-cyclohexylpropionyl)-1-(2-ethoxyphenyl) piperazine (D-16120) by rat liver microsomes.
    Caputo O; Rocco F; Grosa G
    Eur J Drug Metab Pharmacokinet; 1994; 19(4):303-10. PubMed ID: 7737231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on analgesic agents. 13. Metabolic fate of 1-butyrl-4-cinnamylipiperazine hydrochloride(BCP-HCl) in rats.
    Terayama H; Naruke T; Kasai S; Numata M; Nakayama H
    Chem Pharm Bull (Tokyo); 1973 Jan; 21(1):12-20. PubMed ID: 4711509
    [No Abstract]   [Full Text] [Related]  

  • 6. [Metabolism and biotransformation of 2-(3'-N-piperidinopropyl) - benzylphenl ethers].
    Kameníková L; Jindra A
    Pharmazie; 1975 Nov; 30(11):730-2. PubMed ID: 1219775
    [No Abstract]   [Full Text] [Related]  

  • 7. [Interference effect of ketamine (Ketanest) and ethanol].
    Schüppel R; Zange M; Dürr W; Petruch F
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):447-8. PubMed ID: 4253870
    [No Abstract]   [Full Text] [Related]  

  • 8. Biotransformation of sufentanil in liver microsomes of rats, dogs, and humans.
    Lavrijsen K; Van Houdt J; Van Dyck D; Hendrickx J; Lauwers W; Hurkmans R; Bockx M; Janssen C; Meuldermans W; Heykants J
    Drug Metab Dispos; 1990; 18(5):704-10. PubMed ID: 1981724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition and metabolism of codorphone in the rat, dog, and man.
    Leeling JL; Evans JV; Helms RJ; Ryerson BA
    Drug Metab Dispos; 1982; 10(6):649-53. PubMed ID: 6130916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolism of ethyl 4-(3,4,5-Trimethoxycinnamoyl) piperazinyl acetate in rats and dogs.
    Chasseaud LF; Hawkins DR; Fry BJ; Lewis JD; Moore DH; Taylor T; Hathway DE
    Arzneimittelforschung; 1972 Oct; 22(10):1726-32. PubMed ID: 4197737
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on analgesic agents. 1.1a Preparation of 1,2-diphenyl-2-(4-substituted 1-piperazinyl)ethanol derivatives and structure-activity relationships.
    Shimokawa N; Nakamura H; Shimakawa K; Minami H; Nishimura H
    J Med Chem; 1979 Jan; 22(1):58-63. PubMed ID: 106119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zipeprol metabolism in man and in the animal.
    Constantin M; Pognat JF
    Arzneimittelforschung; 1978; 28(1):64-72. PubMed ID: 580201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of in vitro metabolites of 3-ethyl-2,6-dimethyl-4H-pyrido(1,2a)pyrimidin-4-one.
    Jemnitz K; Dénes G; Tamás J; Gács-Baitz E
    Biomed Environ Mass Spectrom; 1989 May; 18(5):308-13. PubMed ID: 2752185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biotransformation of urapidil: isolation and identification of metabolites in mouse, rat, dog and man.
    Sturm E; Zech K
    Biomed Mass Spectrom; 1984 May; 11(5):211-6. PubMed ID: 6743765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics and metabolism of the antihypertensive agent urapidil in rats and dogs].
    Ludwig G; Vergin H; Zech K
    Arzneimittelforschung; 1977; 27(11):2077-86. PubMed ID: 580005
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolism of vanoxerine, 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine, by human cytochrome P450 enzymes.
    Cherstniakova SA; Bi D; Fuller DR; Mojsiak JZ; Collins JM; Cantilena LR
    Drug Metab Dispos; 2001 Sep; 29(9):1216-20. PubMed ID: 11502731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on analgesic drugs. XIV. Absorption, excretion, distribution and metabolism of 1-n-butyry-4-cinnamyl1[gamma-14C]piperazine hydrochloride (BCP-14C) in the rat (author's transl)]].
    Irikura T; Nagatsu Y; Baba S; Sone H
    Yakugaku Zasshi; 1974 Jul; 94(7):802-10. PubMed ID: 4474390
    [No Abstract]   [Full Text] [Related]  

  • 18. Excretion and metabolism of flunarizine in rats and dogs.
    Meuldermans W; Hendrickx J; Hurkmans R; Swysen E; Woestenborghs R; Lauwers W; Heykants J
    Arzneimittelforschung; 1983; 33(8):1142-51. PubMed ID: 6685491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic fate of the novel antihypertensive drug naftopidil.
    Niebch G; Locher M; Peter G; Borbe HO
    Arzneimittelforschung; 1991 Oct; 41(10):1027-32. PubMed ID: 1665973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species differences in the in vitro metabolism of EGYT-475, a new antidepressant agent.
    Fonyó M; Guttmann A; Magyar K
    Pol J Pharmacol Pharm; 1987; 39(2):129-34. PubMed ID: 3432158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.